WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 7 | 8 || 10 |

- 14.03.09 ...

-- [ 9 ] --

249. Liu, G. Modulation of immune responses through direct activation of Toll-like receptors to T cells / G. Liu, L. Zhang, Y. Zhao // Clinical and Experimental Immunology. 2010. N 160. . 168-175.

250. Ljung, O. Intradermal and agglutination tests in tularaemia; with particular regard to the demonstration of past infection // Acta Med. Scand. 1958. N 160. . 149-154.

251. Lofgren, S. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes / S. Lofgren, A. Tarnvik, G.D. Bloom, W. Sjoberg // Infect. Immun. 1983. N 39. . 715-720.

252. Lukaszewski, R.A. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils / R.A. Lukaszewski, D.J. Kenny, R. Taylor, D.G. Rees, M.G. Hartley, P.C. Oyston // Infect. Immun. 2005. N 73 (11).

. 7142-7150.

253. Lund, F.E. Effector and regulatory B cells: modulators of CD4+ T cell immunity / F.E. Lund, T.D. Randall // Nat. Rev. Immunol. 2010. N 10 (4). . 236-247.

254. MacIntyre, S. An extended hydrophobic interactive surface of Yersinia pestis Caf1M chaperone is essential for subunit binding and F1 capsule assembly / S. MacIntyre, I.M. Zyrianova, T.V. Chernovskaya, M. Leonard, E.G. Rudenko, V.P. Zav'Yalov, D.A. Chapman // Mol. Microbiol. 2001. N 39 (1). . 12-25.

255. Makoveichuk, E. pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes / E. Makoveichuk, P. Cherepanov, S. Lundberg, . Forsberg, G. Olivecrona // The Journal of Lipid Research. 2003. N 44. . 320-330.

256. Malik, M. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis / M. Malik, C.S. Bakshi, K. McCabe, S.V. Catlett, A. Shah, R. Singh, P.L. Jackson, A. Gaggar, D.W. Metzger, J.A. Melendez, J.E. Blalock, T.J. Sellati // J. Immunol. 2007. N 178.

. 1013-1020.

257. Markel, G. The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis / G. Markel, E. Bar-Haim, E. Zahavy, H. Cohen, O. Cohen, A. Shafferman, B. Velan // PLoS One. 2010. Vol. 5 (6), N 18.

. 11176.

258. Marketon, M.M. Plague bacteria target immune cells during infection / M.M. Marketon, R.W. DePaolo, K.L. DeBord, B. Jabri, O. Schneewind // Science. 2005. N 309. . 1739-1741.

259. Marohn, M.E. Live Attenuated Tularemia Vaccines: Recent Developments and Future Goals / M.E. Marohn, E.M. Barry // Vaccine. 2013. N 31(35). . 3485-3491.

260. Matsui, W. Anti-tumour activity of interferon-alpha in multiple myeloma:

role of interleukin 6 and tumor cell differentiation / W. Matsui, C.A. Huff, M. Vala, J. Barber, B.D. Smith, R.J. Jones // Br. J. Haematol. 2003. N 121. . 251-258.

261. McCaffrey, R.L. Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis / R.L. McCaffrey, J.T. Schwartz, S.R. Lindemann, J.G. Moreland, B.W. Buchan, B.D. Jones, L.A. Allen // J. Leukoc.

Biol. 2010. N 88. . 791-805.

262. McCaffrey, R.L. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape / R.L. McCaffrey, L.A. Allen // J. Leukoc. Biol. 2006. N 80. . 1224-1230.

263. McCrumb, F.R. Aerosol infection of man with Pasteurella tularensis // Bacteriol. Rev. 1961. N 25. . 262-267.

264. Meyer, K.F. Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine / K.F. Meyer, G. Smith, L.E. Foster, J.D. Marshall, D.C. Cavanaugh // J. Infect. Dis. 1974. N 129.

. 30-36.

265. Millington, K.A. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load / K.A. Millington, J.A. Innes, S. Hackforth, T.S. Hinks, J.J. Deeks, D.P. Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, A. Lalvani // J. Immunol. 2007. N 178. . 5217-5226.

266. Mishell, D.D. Selected methods in cellular immunology / D.D. Mishell, S.M. Shiigi // Freeman San Francisco and Co Oxford, UK. 1980. 486 p.

267. Montminy, S.W. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response / S.W. Montminy, N. Khan, S. McGrath, M.J. Walkowicz, F. Sharp, J.E. Conlon K., Fukase, S. Kusumoto, C. Sweet, K. Miyake, S. Akira, R.J. Cotter, J.D. Goguen, E. Lien // Nat. Immunol. 2006. N 7. . 1066-1073.

268. Morris, S.R. Development of a recombinant vaccine against aerosolized plague // Vaccine. 2007. N 25 (16). . 3115-3117.

269. Mueller, C.A. The V-antigens of Yersinia forms a distinct structure at the tip of injectisome needles / C.A. Mueller, P. Broz, S.A. Muller // Science. 2005. N 310.

. 674-676.

270. Musson, J.A. Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes / J.A. Musson, M. Morton, N. Walker // The Journal of Biological Chemistry. 2006. Vol. 281, N 36. . 26129-26135.

271. Netea, M.G. Toll-like receptors as an escape mechanism from the host defense / M.G. Netea, J.W.M. Van der Meer, B.J. Kullberg // Trends Microbiol. 2004.

N 12. . 484-488.

272. Noel, B.L. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages / B.L. Noel, S. Lilo, D. Capurso, J. Hill, J.B. Bliska // Clin. Vaccine Immunol. 2009. N 16 (10). . 1457-1466.

273. Norris, S.S. Modified Caspase-3 Assay Indicates Correlation of Caspase-3 Activity with Immunity of Nonhuman Primates to Yersinia pestis Infection / S.S. Norris, J. Adamovicz // Clinical vaccine immunology. 2008. N 15 (7). P. 1134-1137.

274. OConnell, F.P. CD138 (Syndecan-1), a Plasma Cell Marker Immunohistochemical Profile in Hematopoietic and Nonhematopoietic Neoplasms / F.P. OConnell, J.L. Pinkus, G.S. Pinkus // Am. J. Clin. Pathol. 2004. N 121. . 254-263.

275. OConnor, W. The dual nature of Th17 cells: shifting the focus to function / W. OConnor, L.A. Zenewicz, R.A. Flavell // Nature Immunology. 2010. Vol. 11, N 6. P. 471-476.

276. Okhrimenko, A. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory / A. Okhrimenko, J.R. Grn, K. Westendorf, Z. Fang, S. Reinke, P. von Roth, G. Wassilew, A.A. Khl, R. Kudernatsch, S. Demski, C. Scheibenbogen, K. Tokoyoda, M.A. McGrath, M.J. Raftery, G. Schnrich, A. Serra, H.D. Chang, A. Radbruch, J. Dong // Proc. Natl.

Acad. Sci. USA. 2014. N 111 (25). . 9229-9234.

277. O'Neill, S.K. Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis / S.K. O'Neill, Y. Cao, K.M. Hamel, P.D. Doodes, G. Hutas, A. Finnegan // J. Immunol. 2007. N 179. . 5109-5116.

278. Onishi, R.M. Interleukine-17 and its target genes: mechanisms of IL-17 function in disease / R.M. Onishi, S.L. Gaffen // Immunology. 2010. N 129. . 311-321.

279. Overheim, K.A. LcrV plague vaccine with altered immunomodulatory properties / K.A. Overheim, R.W. Depaolo, K.L. Debord, E.M. Morrin, D.M. Anderson, N.M. Green // Infect. Immun. 2005. N 73. . 5152-5159.

280. Overholt, E.L. An analysis of forty-two cases of laboratory-acquired tularemia: treatment with broad-spectrum antibiotics / E.L. Overholt, W.D. Tigertt, P.J. Kadull, M.K. Ward, N.D. Charkes, R.M. Rene, T.E. Salzman, S. Mallory // Am. J.

Med. Sci. 1961. N 30. . 785-791.

281. Oyston, P.C. Prophylaxis and therapy of plague / P.C. Oyston, E.D. Williamson // Expert Rev Anti Infect Ther. 2013. N 11 (8). . 817-829.

282. Oyston, P.C. Tularemia vaccine: past, present and future / P.C. Oyston, J.E. Quarry // Antonie Van Leeuwenhoek. 2005. Vol. 87. P. 277-281.

283. Oyston, P.C. Tularaemia: bioterrorism defence renews interest in Francisella tularensis / P.C. Oyston, A. Sjstedt, R.W. Titball // Nat. Rev. Microbiol. 2004. N 2. . 967-978.

284. Parent, M.A. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection / M.A. Parent, L.B. Wilhelm, L.W. Kummer, F.M. Szaba, I.K. Mullarky, S.T. Smiley // Infect Immun. 2006. N 74 (6). . 3381-3386.

285. Parent, M.A. Cell-mediated protection against pulmonary Yersinia pestis infection / M.A. Parent, K.N. Berggren, L.W. Kummer, L.B. Wilhelm, F.M. Szaba, I.K. Mullarky, S.T. Smiley // Infect. Immun. 2005. N 73. . 7304-7310.

286. Pepper, M. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells / M. Pepper, J.L. Linehan, A.J. Pagn, T. Zell, T. Dileepan, P.P. Cleary, M.K. Jenkins // Nat Immunol. 2010. N 11 (1). . 83-89.

287. Periasamy, S. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia / S. Periasamy, A. Singh, B. Sahay, T. Rahman, P.J. Feustel, G.H. Pham, E.J. Gosselin, T.J. Sellati // J. Leukoc. Biol. 2011. N 90 (3). . 493-507.

288. Perry, R.D. Yersinia pestis: etiologic agent of plague / R.D. Perry, J.D. Fetherston // Clin. Microbiology Rev. 1997. N 10. . 35-66.

289. Persson, C. Cell surface bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into target cell / C. Persson, R. Nordfelth, A. Holstorm, S. Hkansson, R. Rosqvist // Mol. Biol. 1995. N 18. P. 135-150.

290. Pettersson, J. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation / J. Pettersson, A. Holmstrom, J. Hill, S. Leary, E. Frithz-Lindsten, A. von Euler-Matell, E. Carlsson, R. Titball, A. Forsberg, H. Wolf-Watz // Mol. Microbiol. 1999. N 32. . 961-976.

291. Philipovskiy, A.V. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection / A.V. Philipovskiy, S.T. Smiley // Infect Immun. 2007. N 75. . 878-885.

292. Philipovskiy, A.V. Antibody against V antigen prevents Yopdependent growth of Yersinia pestis / A.V. Philipovskiy, C. Cowan, C. Wulff-Strobel, S.H. Burnett, E.J. Kerschen, D.A. Cohen, A.M. Kaplan, S.C. Straley // Infect. Immun. 2005. N 73 (3). . 1532-1542.

293. Pierini, L.M. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors // Cell. Microbiol. 2006.

N 8. . 1361-1370.

294. Pouliot, K. Evaluation of the Role of LcrVToll-Like Receptor 2-Mediated Immunomodulation in the Virulence of Yersinia pestis / K. Pouliot, N. Pan, S. Wang, S. Lu, E. Lien, J.D. Goguen // Infection and immunity. 2007. N 75 (7). . 3571-3580.

295. Pradel, E. New Insights into How Yersinia pestis Adapts to Its Mammalian Host during Bubonic Plague / E. Pradel, N. Lematre, M. Merchez, I. Ricard, A. Reboul, A. Dewitte, F. Sebbane // PLOS Pathogens. 2014. N 10 (3). . e 1004029.

296. Proctor, R.A. Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes / R.A. Proctor, J.D. White, E. Ayala, P.G. Canonico // Infect.

Immun. 1975. N 11. . 146-151.

297. Pujol, C. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis / C. Pujol, J.B. Bliska // Infect. Immun.

2003. N 71. . 5892-5899.

298. Pujol, C. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae / C. Pujol, J.B. Bliska // Clin. Immunol.

2005. N 114 (3). . 216-226.

Yersinia pestis

299. Pujol, C. Replication of in interferon--activated macrophages requires ripA, a gene encoded in the pigmentation locus / C. Pujol, J.P. Grabenstein, R.D. Perry, J.B. Bliska // Proc. Natl Acad. Sci. USA. 2005. N 102 (36). . 12909-12914.

300. Qiu, Y. Comparison of Immunological Responses of Plague Vaccines F1+rV270 and EV76 in Chinese-Origin Rhesus Macaque, Macaca mulatta / Y. Qiu, Y. Liu, Z. Qi, W. Wang, Z. Kou, Q. Zhang, G. Liu, T. Liu, Y. Yang, X. Yang, Y. Xin, C. Li, B. Cui, S. Huang, H. Liu, L. Zeng, Z. Wang, R. Yang, H. Wang, X. Wang // Scandinavian Journal of Immunology. 2010. N 72. . 425-433.

301. Quenee, L.E. Plague vaccines and the molecular basis of immunity against Yersinia pestis / L.E. Quenee, O. Schneewind // Hum. Vaccin. 2009. N 5. . 817Rajaram, M.V. Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway / M.V. Rajaram, J.P. Butchar, K.V. Parsa, T.J. Cremer, A. Amer, L.S. Schlesinger, S. Tridandapani // PLoS One. 2009. N 4. . e7919.

303. Rajerison, M. Development and Evaluation of Two Simple, Rapid Immunochromatographic Tests for the Detection of Yersinia pestis Antibodies in Humans and Reservoirs / M. Rajerison, S. Dartevelle, L.A. Ralafiarisoa, I. Bitam, Dinh Thi Ngoc Tuyet, Voahangy Andrianaivoarimanana, Faridabano Nato, Lila Rahalison // PLoS Negl Trop Dis. 2009. N 3 (4). . e 421.

304. Rasoamanana, B. Field evaluation of an immunoglobulin Ganti-F1enzymelinked immunosorbent assay for serodiagnosis of human plague in Madagascar / B. Rasoamanana, F. Leroy, P. Boisier, M. Rasolomaharo, P, Buchy, E. Carniel, S. Chanteau // Clin. Diagn. Lab. Immunol. 1997. N 4. . 587-591.

305. Reddy, M. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cellcultures: an in vitro model to monitor cellular immune function / M. Reddy, E. Eirikis, C. Davis, H.M. Davis, U. Prabhakar // J. Immunol. Methods. 2004. N 293 (1-2). . 127-142.

306. Reilly, T.J. Characterization of recombinant Francisella tularensis acid phosphatase A / T.J. Reilly, R.L. Felts, M.T. Henzl, M.J. Calcutt, J.J. Tanner // Protein Expr Purif. 2006. N 45. . 132-141.

307. Reithmeier-Rost, D. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis / D. Reithmeier-Rost, J. Hill, S.J. Elvin, D. Williamson, S. Dittmann, A. Schmid, G. Wilharm, A. Sing // Microbes Infect. 2007. N 9 (8). . 997-1002.

308. Riha, P. CD28 co-signaling in the adaptive immune response / P. Riha, C.E. Rudd // Self Nonself. 2010. N 1 (3). . 231-240.

309. Rodriguez, A.R. Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification / A.R. Rodriguez, J.J. Yu, A.K. Murthy, M.N. Guentzel, K.E. Klose, T.G. Forsthuber, J.P. Chambers, M.T. Berton, B.P. Arulanandam // Mucosal Immunol.

2011. - 4 (2). . 217-226.

310. Rosenzweig, J.A. The future of plague vaccines: hopes raised by a surrogate, live-attenuated recombinant vaccine candidate / J.A. Rosenzweig, A.K. Chopra // Expert Rev. Vaccines. 2012. N 11 (6). . 659-661.

311. Rosqvist, R. Target cell contact triggers expression and polarization transfer of Yersinia YopE cytotoxin into mammalian cells / R. Rosqvist, K.E. Magnusson, H.Wolf-Woatz // EMDO J. 1994. N 13. P.964-972.

312. Rosqvist, R. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption / R. Rosqvist, A. Forsberg, H. Wolf-Woatz // Infect. Immunol. 1991. N 59. P. 4562-4569.

313. Roy, M. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses / M. Roy, A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, R. Noelle // Eur. J. Immunol. 1995. N 25. . 596-603.

314. Rozkov, D. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation / D. Rozkov, L. Novotn, R. Pytlk, I. Hochov, T. Kozk, J. Bartnkov, R. Spsek // Int. J. Cancer. 2010. N 126 (5). . 1132-1143.

315. Russell, P. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murinemodel / P. Russell, S.M. Eley, S.E. Hibbs, R.J. Manchee, A.J. Stagg, R.W. Titball // Vaccine. 1995. N 13. . 1551-1556.

316. Rykova, V.A. The autoagglutination factor of plague pathogen--crossreacting antigen / V.A. Rykova, L.K. Lysova, O.N. Podladchikova // Klin Lab Diagn. 2009. N 7. . 22-24.

317. Sabhnani, L. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains / L. Sabhnani, M. Manocha, D. Tomar, D. Shashikiran, D.N. Rao // Int.

Immunopharmacol. 2003. N 3. . 1413-1418.

318. Sadik, C.D. Neutrophils cascading their way to inammation / C.D. Sadik, N.D. Kim, A.D. Luster // Trends Immunol. 2011. N 32. . 452-460.

319. Salek-Ardakani, S. B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus / S. Salek-Ardakani, Y.S. Choi, M. Rafii-El-Idrissi Benhnia, R. Flynn, R. Arens, S. Shoenberger, S. Crotty, M. Croft // J. Immunol. 2011. N 186. . 5294-5303.

320. Salerno-Goncalves, R. Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans / R. Salerno-Goncalves, M.J. Hepburn, S. Bavari, M.B. Sztein // Vaccine. 2009. N 28. . 195-206.

321. Sanchez-Lockhart, M. A role for inside-out signaling in T cell receptor regulation of CD28 ligand binding / M. Sanchez-Lockhart, M. Kim, J. Miller // J. Immunol. 2011. N 187 (11). . 5515-5519.

322. Santic, M. Intra-Vacuolar Proliferation of F. Novicida within H.

Vermiformis / M. Santic, M. Ozanic, V. Semic, G. Pavokovic, V. Mrvcic, Y.A. Kwaik // Front. Microbiol. 2011. N 2. . 78.

323. Santic, M. Acquisition of the vacuolar ATPase proton pump and phagosome acidification are essential for escape of Francisella tularensis into the macrophage cytosol / M. Santic, R. Asare, I. Skrobonja, S. Jones, Y. Abu Kwaik // Infect. Immun. 2008. N 76. . 2671-2677.

324. Santic, M. A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol / M. Santic, M. Molmeret, J.R.Barker, K.E. Klose, A. Dekanic, M. Doric, Y. Abu Kwaik // Cell Microbiol. 2007. N 9. . 23912403.

325. Saslaw, S. Tularemia vaccine study. II. Respiratory challenge / S. Saslaw, H.T. Eigelsbach, J.A. Prior, H.E. Wilson, S. Carhart // Arch Intern Med. 1961. N 107. . 702-714.

326. Saslaw, S. Tularemia vaccine study. I. Intracutaneous challenge / S. Saslaw, H.T. Eigelsbach, H.E. Wilson, J. Prior, S. Carhart // Arch. Int. Med. 1961. N 107. . 121-133.

327. Schmitt, P. A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia / P. Schmitt, W.

Splettstsser, M. Porsch-Ozcrmez, E.J. Finke, R. Grunow // Epidemiol Infect. 2005. N 133 (4). . 759-766.

328. Schnare, M. Toll-like receptors control activation of adaptive immune responses / M. Schnare, G.M. Barton, A.C. Holt, K. Takeda, S. Akira, R. Medzhitov // Nat. Immunol. 2001. N 2 (10). . 947-950.

329. Schriever, F. Isolated human follicular dendritic cells display a unique antigenic phenotype / F. Schriever, A.S. Freedman, G. Freeman // J. Exp. Med. 1989.

N169. . 2043-2058.

330. Schulert, G.S. Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor / G.S. Schulert, L.A. Allen // J. Leukoc. Biol. 2006. N 80. . 563-571.

331. Sebbane, F. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague / F. Sebbane, N. Lemaitre, D.E. Sturdevant, R. Rebeil, K. Virtaneva, S.F. Porcella, B.J. Hinnebusch // Proc. Natl Acad. Sci. USA.

2006. N 103 (31). . 11766-11771.

332. Sebbane, F. Kinetics of disease progression and host response in a rat model of bubonic plague / F. Sebbane, D. Gardner, D. Long, B.B. Gowen, B.J. Hinnebusch // Am. J. Pathol. 2005. N 166. . 1427-1439.

333. Seder, R.A. T-cell quality in memory and protection: implications for vaccine design / R.A. Seder, P.A. Darrah, M. Roederer // Nat Rev Immunol. 2008. N 8. . 247-258.

334. Seder, R.A. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation / R.A. Seder, R. Ahmed // Nat Immunol. 2003. N 4. . 835-842.

Yu X.. Strong CD28 costimulation suppresses induction of

335. Semple, K.

regulatory T cells from naive precursors through Lck signaling / K. Semple, A. Nguyen, Yu Yu, H. Wang, C. Anasetti // Blood. 2011. N 117 (11). . 3096Shannon, J.G. Yersinia pestis subverts the dermal neutrophil response in a mouse model of bubonic plague / J.G. Shannon, A.M. Hasenkrug, D.W. Dorward, V. Nair, A.B. Carmody, B.J. Hinnebusch // MBio. 2013. N 27;4(5). . e 00170-13.

337. Sheikh, N.A. Delivery systems for molecular vaccination / N.A. Sheikh, M. al-Shamisi, W.J.W. Morrow // Curr. Opin. Mol. Ther. 2000 N 2. . 37-54.

338. Shim, H.K. Mechanisms of major histocompatibility complex class IIrestricted processing and presentation of the V antigen of Yersinia pestis / H.K. Shim, J.A. Musson, H.M. Harper // Immunology. 2006. N 119 (3). . 385-392.

339. Shipkova, M. Surface markers of lymphocyte activation and markers of cell proliferation / M. Shipkova, E. Wieland // Clin Chim Acta. 2012. N 413 (17/18). . 1338-1349.

340. Sing, A. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence / A. Sing, D. Reithmeier-Rost, K. Granfors, J. Hill, A. Roggenkamp, J. Heesemann // Proceedings of the National Academy of Sciences of the United States of America. 2005. N 102 (44). . 16049-16054.

341. Sjstedt, A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations // Ann. N. Y. Acad. Sci. 2007. N 1105. . 1-29.

342. Sjstedt, A. The requirement of tumour necrosis factor-alpha and interferongamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculums / A. Sjstedt, R.J. North, J.W. Conlan // Microbiology. 1996. N 142. . 1369-1374.

343. Sjstedt, A. Various membrane proteins of Francisella tularenisis induce interferon- production in both CD4+ and CD8+ T cells of primed humans / A. Sjstedt, M. Eriksson, G. Sandstrm, A. Trnvik // Immunology. 1992. N 76. . 584-592.

344. Smiley, S.T. Current challenges in the development of vaccines for pneumonic Plague // Expert Rev Vaccines. 2008. N 7 (2). . 209-221.

345. Smiley, S.T., Cell-mediated defense against Yersinia pestis infection // Advancesin Experimental Medicine and Biology. 2007. N 603. . 376-386.

346. Sodeinde, O.A., A surface protease and the invasive character of plague / O.A. Sodeinde, Y.V. Subrahmanyam, K. Stark, T. Quan, Y. Bao, J.D. Goguen // Science. 1992. N 6 (258). .1004-1007.

347. Sokolova, E.P. Effect of Yersinia pestis EV 76 lypopolysaccharides with different levels of toxicity on dynamics of TNF-alpha and INF-gamma synthesis by human monocytes / E.P. Sokolova, G.V. Demidova, V.P. Ziuzina, L.P Alekseeva, I.A. Bespalova, V.I. Tynianova // Zh. Mikrobiol. Epidemiol.

Immunobiol. 2010. N 4. . 59-64.

348. Splettstoesser, W. Evaluation of an Immunochromatographic Test for Rapid and Reliable Serodiagnosis of Human Tularemia and Detection of Francisella tularensis-Specic Antibodies in Sera from Different Mammalian Specie / W. Splettstoesser, V. Guglielmo-Viret, E. Seibold, P. Thullier // J. Clin Microbiol. 2010. N 5. . 1629-1634.

349. Stack, R.M. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2 / R.M. Stack, D.J. Lenschow, G.S. Gray, J.A. Bluestone, F.W. Fitch // J. Immunol. 1994. N 152. . 5723-5733.

350. Stapp, P. Exposure of small rodents to plague during epizootics in blacktailed prairie dogs / P. Stapp, D.J. Salkeld, R.J. Eisen, R. Pappert, J. Young, L.G. Carter, K.L. Gage, D.W. Tripp, M.F. Antolin // J. Wild Dis. 2008. N 44 (3). .724-730.

351. Steiner, D.J. Hostpathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity / D.J. Steiner, Y. Furuya, D.W. Metzger // Infect Drug Resist. 2014. N 7. . 239-251.

352. Stenmark, S. Specic antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica / S. Stenmark, H. Lindgren, A. Tarnvik, A. Sjostedt // Microb. Pathog. 2003. N 35. . 73-80.

353. Subauste, C.S. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: Dendritic cell activation after infection with viable parasites results in CD28 and CD40 Ligand signaling that controls IL-12-dependent and

-independent T cell production of IFN- / C.S. Subauste, M. Wessendarp // J. Immunol.

2000. N 165. .1498-1505.

354. Subauste, C.S. CD40 - CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: Patients with hyper IgM syndrome have a defective type-1 immune response which can be restored by soluble CD40L trimer / C.S. Subauste, M. Wessendarp, R.U. Sorensen, L. Leiva // J. Immunol. 1999. N 162. . 6690-6700.

355. Sugimoto, K. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation / K. Sugimoto, A. Ogawa, Y. Shimomura, K. Nagahama, A. Mizoguchi, A.K. Bhan // Gastroenterology. 2007. N 133. . 124-136.

356. Sun, W. Developing live vaccines against Yersinia pestis / W. Sun, K.L. Roland, R. Curtiss // J. Infect Dev Ctries. 2011. N 5. . 614-627.

357. Suvas, S. Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma / S. Suvas, V. Singh, S. Sahdev, H. Vohra, J.N. Agrewala // The Journal of Biological Chemistry. 2002. N 277. . 7766-7775.

358. Syrjl, H. A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia / H. Syrjl, E. Herva, J. Ilonen, K. Saukkonen, A. Salminen // J. Infect. Dis. 1984. N 150. . 912-915.

359. Szaba, F.M. TNFa and IFNc but Not Perforin Are Critical for CD8 T CellMediated Protection against Pulmonary Yersinia pestis Infection / F.M. Szaba, L.W. Kummer, D.K. Duso, E.P. Koroleva, A.V. Tumanov, A.M. Cooper, J.B. Bliska, S.T. Smiley, Lin. Jr-Shiuan // PLOS Pathogens. 2014. N 10 (5). . e1004142.

360. Szaba, F.M. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague / F.M. Szaba, L.W. Kummer, L.B. Wilhelm, J.S. Lin, M.A. Parent, S.W. Montminy-Paquette, E. Lien, L.L. Johnson, S.T. Smiley // Infect Immun. 2009. N 77. . 4295-4304.

361. Takahashi, K. Pathogen recognition by Toll-like receptor / K. Takahashi, T. Kawai // Nippon Rinsho. 2007. N 65. . 53-57.

362. Takeda K., Toll-like receptors / K. Takeda, T. Kaisho, S. Akira // Annu Rev.

Immunol. 2003. N 21. . 335-376.

363. Takeda, K. Regulation of innate immune responses by Toll-like receptors / K. Takeda, S. Akira // Jpn. J. Infect. Dis. 2001. N 54. . 209-219.

364. Tamimoto, Y. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines / Y. Tamimoto, T. Horiuchi, H. Tsukamoto, J. Otsuka, H. Mitoma, Y. Kimoto, H. Nakashima, K. Muta, Y. Abe, C. Kiyohara, A. Ueda, K. Nagasawa, S. Yoshizawa, T. Shimoda, M. Harada // Rheumatology (Oxford). 2008. N 47. . 821-827.

365. Trnvik, A. Francisella tularensis a model for studies of the immune response to intracellular bacteria in man / A. Trnvik, M. Eriksson, G. Sandstrm, A. Sjstedt // Immunology. 1992. N 76. . 349-54.

366. Trnvik, A. Longlasting cell-mediated immunity induced by a live Francisella tularensis vaccine / A. Trnvik, M.L. Lfgren, S. Lfgren, G. Sandstrm, H. Wolf-Watz // J. Clin Microbiol. 1985. N 22. . 527-530.

367. Trnvik, A. Time of lymphocyte response after onset of tularemia and after tularemia vaccination / A. Trnvik, G. Sandstrm, S. Lofgren // J. Clin. Microbiol. 1979. N 10. P. 854-860.

368. Taye, K.J. Development of vaccine against plague, glanders and melioidosis:

Trends in the research during the times of cold war and today: Doctor medicinae veterinariae (Dr. med. vet.). Leipzig, 2010. 174 .

369. Testi, R. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells / R. Testi, D. D'Ambrosio, R. De Maria, A. Santoni // Immunol.

Today. 1994. N 15 (10). . 479-483.

370. Thakran, S. Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer / S. Thakran, H. Li, C.L.

Lavine, M.A. Miller, J.E. Bina, X.R. Bina, F. Re // J. Biol. Chem. 2008. N 283. . 3751-3760.

371. Thomas, R.M. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens / R.M. Thomas, R.W. Titball, P.C. Oyston, K. Griffin, E. Waters, P.G. Hitchen, S.L. Michell, I.D. Grice, J.C. Wilson, J.L. Prior // Infect. Immun. 2007. N 75. . 371-378.

372. Thorpe, B.D. Phagocytosis and intracellular fate of Pasteurella tularensis: in vitro effects of exudate stimulants and streptomycin on phagocytic cells / B.D. Thorpe, S. Marcus // J. Reticuloendothel. Soc. 1967. N 4. . 10-23.

373. Tigertt, W.D. Soviet viable Pasteurella tularensis vaccines. A review of selected articles // Bacteriol. Rev. 1962. N 26. . 354-373.

374. Titball, R.W. A vaccine for tularaemia / R.W. Titball, P. C. Oyston // Expert Opin. Biol. Ther. 2003. Vol. 3. P. 645-653.

375. Townsend, S.E. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo / S.E. Townsend, C.C. Goodnow // J. Exp Med. 1998. N 187. . 1611-1621.

376. Tung, J.W. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse / J.W. Tung, M.D. Mrazek, Y. Yang, L.A. Herzenberg // Proc. Natl. Acad. Sci. USA. 2006. N 103. . 6293-6298.

377. Une, T. In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of Yersiniae / T. Une, R.R. Brubaker // Infect. Immun. 1984. N 43. . 895-900.

378. Vagima, Y. Earlysensing of Yersinia pestis airway infection by bone marrow cells / Y. Vagima, Y. Levy, D. Gur, A. Tidhar, M. Aftalion, H. Abramovich, E. Zahavy, A. Zauberman, Y. Flashner, A. Shafferman, E. Mamroud // Frontiers in Cellular and Infection Microbiology. 2012. N 2 .143-147.

379. Vazquez, B.N. CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements / B.N. Vazquez, T. Laguna, J. Carabana, M.S. Krangel, P. Lauzurica // J. Immunol. 2009. N 183 (10). . 6513-6521.

380. Vega-Ramos, J. CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection / J. Vega-Ramos, E. AlariPahissa, J.D. Valle, E. Carrasco-Marn, E. Esplugues, M. Borrs, A.C. Martnez, P. Lauzurica // Immunol. Cell Biol. 2010. N 88 (7). .707-715.

381. Velan, B. Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration / B. Velan, E. Bar-Haim, A. Zauberman, E. Mamroud, A. Shafferman, S. Cohen // Infect. Immun. 2006. N 74. . 6365-6376.

382. Viboud, G.I. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis / G.I. Viboud, J.B. Bliska // Annu. Rev.

Microbiol. 2005. N 59. . 69-89.

383. Waag, D.M. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis / D.M. Waag, K.T.Jr. McKee, G. Sandstrom, L.L. Pratt, C.R. Bolt, M.J. England, G.O. Nelson, J.C. Williams // Clin. Diagn. Lab. Immunol. 1995. N 2. . 143-148.

384. Wagner, M. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 Ligand and CpG DNA / M. Wagner, H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prel, B. Bohle, E. Tuma, T. Giese, J.W. Ellwart, S. Endres, G. Hartmann // J. Immunol. 2004. N 172 (2). . 954-963.

385. Wake, A. Mechanims of protection against virulent Yersinia pestis infection without participation of humoral antibody: H-2 restriction in athymic mouse model / A. Wake, Y. Sutoh // Curr. Microbiol. 1983. N 8. . 79-84.

386. Wang, X. Serum cytokine responses in primary pneumonic plague patients / X. Wang, Z. Wang, Z. Guo, B. Wei, F. Tian, S. Yu, H. Wang, R. Yang // Clin.

Vaccine Immunol. 2011. N 18. . 184-186.

387. Wayne Conlan. Infection of Mice with Francisella as an Immunological Model / W.J. Conlan, W. Chen, C.M. Bosio, S.C. Cowley, K.L. Elkins // Curr Protoc Immunol. 2011. N 4. Unit 19.14.

388. Weeks, S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis / S. Weeks, J. Hill, A. Friedlander, S. Welkos // Microb. Pathog. 2002. N 32 (5). . 227-237.

389. Welkos, S. V antigen of Yersinia pestis inhibits neutrophil chemotaxis / S. Welkos, A. Friedlander, D. McDowell, J. Weeks, S. Tobery // Microb. Pathog. 1998. N 24 (3). . 185-196.

390. Wherry, E.J. Memory CD8 T-cell differentiation during viral infection / E.J. Wherry, R. Ahmed // J. Virol. 2004. N 78 (11). . 5535-5545.

391. Wickstrum, J.R. Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice / J.R. Wickstrum, S.M. Bokhari, J.L. Fischer, D.M. Pinson, H.W. Yeh, R.T. Horvat, M.J. Parmely // Infect. Immun. 2009. N 77. . 4827-4836.

392. Wickstrum, J.R. Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis / J.R. Wickstrum, K.J. Hong, S. Bokhari, N. Reed, N. McWilliams, R.T. Horvat, M.J. Parmely // Infect. Immun. 2007. N 5. . 1335-1342.

393. Williams, J.E. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Nambia 1982 / J.E. Williams, L. Arntzen, G.L. Tyndal, M. Isaacson // Bull World Health Organ. 1986. N 64. . 745-752.

394. Williamson, E.D. Plague vaccines. Vaccines Elsevier / E.D. Williamson, P.C. Oyston. 6-th edition. 2013. 573 p.

395. Williamson, E.D. Protecting against plague: towards a next-generation vaccine / E.D. Williamson, P.C. Oyston // Clin. Exp. Immunol. 2013. N 172 (1). . 1-8.

396. Williamson, E.D. The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague // Advances in Preventive Medicine. 2012. 7 p.

397. Williamson, E.D. Plague in: vaccines for biodefense, supplement to vaccine // Vaccine. 2009. Vol. 27. P. D56-D60.

398. Williamson, E.D. Immunogenicity of the rF1+rV vaccine with the identication of potential immune correlates of protection / E.D. Williamson, H.C. Flick- Smith, E.L. Waters // Microbial Pathogens. 2007. Vol. 42, N 1. . 12-22.

399. Williamson, E.D. Human immune response to a plague vaccine comprising recombinant F1 and rV antigens / E.D. Williamson, H.C. Flick-Smith, C. LeButt // Infection and Immunity. 2005. Vol.73, N 6. . 3598-3608.

400. Williamson, E.D. Presentation of protective antigen to the mouse immune system: immune sequelae / E.D. Williamson, R.J. Beedham, A.M. Bennett, S.D. Perkins, J. Miller, L.W. Baillie // Journal of applied microbiology. 1999. N 87.

. 315-317.

401. Williamson, E.D. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model / E.D. Williamson, P.M. Vesey, K.J. Gillhespy, S.M. Eley, M. Green, R.W. Titball // Clinical and Experimental Immunology. 1999. Vol. 116, N 1. . 107-114.

402. Williamson, E.D. A new improved sub-unit vaccine for plague: the basis of protection / E.D. Williamson, S.M. Eley, K.F. Grin // FEMS Immunology and Medical Microbiology. 1995. Vol. 12, N 3/4. . 223-230.

403. Winkler, S. Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa / S. Winkler, M. Necek, H. Winkler, A.A. Adegnika, T. Perkmann, M. Ramharter, P.G. Kremsner // Microbes Infect. 2005. N 7 (9/10). . 1161-1169.

404. Woolard, M.D. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells / M.D. Woolard, L.L. Hensley, T.H. Kawula, J.A. Frelinger // Infect. Immun. 2008. N 76. . 2651-2659.

405. Wu, T.H. Intranasal Vaccination Induces Protective Immunity against Intranasal Infection with Virulent Francisella tularensis Biovar A / T.H. Wu, J.A. Hutt, K.A. Garrison, L.S. Berliba, Y. Zhou, C.R. Lyons // Infection and immunity. 2005. N 73 (5). . 2644-2654.

406. Xiao, Z. Cytotoxic T Lymphocytes and Vaccine Development / Z. Xiao, K. Klonowski, H. Yang, J. Curtsinger // Journal of Biomedicine and Biotechnology. 2011. Article ID 756864. . 1-13.

407. Xu, Y. The role of CD40-CD154 interaction in cell immunoregulation / Y.Xu, G. Song // J. Biomed Sci. 2004. N 11 (4). . 426-438.

408. Xue, J. Regulation of galectin-3-induced apoptosis of Jurkat cells by both O-glycans and N-glycans on CD45 / J. Xue, X. Gao, C. Fu, Z. Cong, H. Jiang, W.Wang, T. Chen, Q. Wei, C. Qin // FEBS Lett. 2013. N 587 (24). . 3986-3994.

409. Yamashita, S. Structural insights into Ail-mediated adhesion in Yersinia pestis / S. Yamashita, P. Lukacik, T.J. Barnard, N. Noinaj, S. Felek, T.M. Tsang, E.S. Krukonis, B.J.Hinnebusch, S.K. Buchanan // Structure. 2011. N 19. . 1672Yang, Y. Antigen-specic memory in B-1a and its relationship to natural immunity / Y. Yang, E.E. Ghosn, L.E. Cole, T.V. Obukhanych, P. Sadate-Ngatchou, S.N. Vogel, L.A. Herzenberg, L.A. Herzenberg // PNAS. 2012. Vol. 109, N 14. P.5388-5393.

411. Yazg, H. Tularemia seroprevalence in the risky population living in both rural and urban areas of Erzurum / H. Yazg, M.H. Uyank, M. Ertek, S. Kl, E. Kireci, K. Ozden, A. Ayyldz // Mikrobiyol Bul. 2011. N 45 (1). . 67-74.

412. Yidong Du. Role of Fraction 1 Antigen of Yersinia pestis in Inhibition of Phagocytosis / Y. Du, R. Rosqvist,. Forsberg // Infect. Immun. 2002. N 70 (3) .

1453-1460.

413. Ylipalosaari, P. Guillain-Barr syndrome and ulceroglandular tularemia / P. Ylipalosaari, T.I. Ala-Kokko, H. Tuominen, H. Syrjl // Infection. 2013. N 41 (4). . 881-883.

414. Yu, J.J. The presence of infectious extracellular Francisella tularensis subsp. Novicida in murine plasma after pulmonary challenge / J.J. Yu, E.K. Raulie, A.K. Murthy, M.N. Guentzel, K.E. Klose, B.P. Arulanandam // Eur. J. Clin. Microbiol.

Infect. Dis. 2008. N 27. . 323-325.

415. Zand, M.S. A renewable source of donor cells for repetitive monitoring of Tand B-cell alloreactivity / M.S. Zand, A. Bose, T. Vo, M. Coppage, T. Pellegrin, L. Arend, F.E. Lee, A. Bozorgzadeh, N. Leong // Am. J. Transplant. 2005. N 5. . 76-86.

416. Zarrella, T.M. Host-Adaptation of Francisella tularensis Alters the Bacterium's Surface-Carbohydrates to Hinder Effectors of Innate and Adaptive Immunity / T.M. Zarrella, A. Singh, C. Bitsaktsis, T. Rahman, B. Sahay, P.J. Feustel, E.J. Gosselin, T.J. Sellati, K.R. Hazlett // PLoS One. 2011. N 6 (7). . e22335.

417. Zauberman, A. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague / A. Zauberman, S. Cohen, Y. Levy, G. Halperin, S. Lazar, B. Velan, A. Shafferman, Y. Flashner, E. Mamroud // Vaccine. 2008. N 26 (13). . 1616-1625.

418. Zav'yalov, V.P. pH 6 antigen (PsaA protein) of Yersinia pestis, a novel bacterial Fc-receptor / V.P. Zav'yalov, V.M. Abramov, P.G. Cherepanov, G.V. Spirina, T.V. Chernovskaya, A.M. Vasiliev // FEMS Immunol Med Microbiol. 1996. N 14 (1). . 53-57.

419. Zav'yalov, V.P. Influence of the conserved disulphide bond, exposed to the putative binding pocket, on the structure and function of the immunoglobulin-like molecular chaperone Caf1M of Yersinia pestis / V.P. Zav'yalov, T.V. Chernovskaya, D.A. Chapman, A.V. Karlyshev, S. MacIntyre, A.V. Zavialov, A.M. Vasiliev, A.I.

Denesyuk, G.A. Zav'yalova, I.V. Dudich, T. Korpela, V.M. Abramov // Biochem. J. 1997. N 324 (2). . 571-578.

420. Zhan,g S.S. Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination / S.S. Zhang, C.G. Park, P. Zhang, S.S. Bartra, G.V. Plano, J.D. Klena, M. Skurnik, B.J. Hinnebusch, T. Chen // J. Biol. Chem. 2008. N 283. . 31511-31521.

421. Zhang, X. A live attenuated strain of Yersinia pestis yscB provides protection against bubonic and pneumonic plagues in mouse model / X. Zhang, Z. Qi, Z. Du, Y. Bi, Q. Zhang, Y. Tan, H. Yang, Y. Xin, R. Yang, X. Wang // Vaccine. 2013. N 31 (22). . 2539-2542.

422. Zheng, J. ICOS Regulates the Generation and Function of Human CD4+ Treg in a CTLA-4 Dependent Manner / J. Zheng, P.L. Chan, Y. Liu, G. Qin, Z. Xiang, K.T. Lam, D.B. Lewis, Y.L. Lau, W. Tu // PLoS One. 2013. N 8 (12). . e82203.

, :

)

1. , .. , / .. , .. , .. , .. , .. , .. , .. , .. , .. // . 2005, 2(90). . 58-59.

2. , .. in vitro / .. , .. , .. , .. , .. , .. // . 2007. 1(93). . 81-84.

3. Firstova, V.V. Evaluation of antitularemia immunity via whole human blood leukocyte cytofluorometric analysis / V.V. Firstova, A.L. Kravtsov, T.P. Schmelkova, T.N. Shchukovskaya // Proceedings of SPIE - The International Society for Optical Engineering. 2005. N 5771. . 311-315.

4. , .. - / .. , .. , .. , .. , .. , .. , .. , .. , .. // , . 2007. 3. . 16-21.

5. , .. CD69 / .. , .. , .. , .. , .. , .. // . 2009. . 11, 4-5.

. 336-337.

6. , .. CD69 / .. , .. , .. , .. , .. , .. , .. , .. , .. // . 2010. 1 (103). . 56-59.

7. , .. Yersinia / / .. , .. , .. , .. // . 2012. 1 (111). . 54-56.

8. , .. , / .. , .. , .. , .. , .. , .. , .. // . 2012. . 7, 2. .96-102.

9. The in vitro evaluation of anti-plague cellular immunity by quantitative analysis of IFN- synthesis and the appearance of activation molecules on the surface of T-helper cells/ Advances in Yersinia Research / Alzira Maria Paiva de Almedia, Nilma Cintra Leal // Advances in experimental medicine and biology. Springer Science.

Business Media New York, 2012. Vol. 954, Part 4. P. 173-177.

10. , .. - , , in vitro / .. , .. , .. , .. , .. , .. // 2012. 4 (14). .73-76.

11. Firstova, V.V. Immunological Markers that Correlate with Protection Immunity Against Tularemia Infection / V.V. Firstova, A.N. Mokrievich, V.M. Pavlov, A.A. Gorbatov, S.F. Biketov, I.A. Dyatlov // Adv Exp Med Biol. 2014, N 808. . 15-23.

12. , .. balb/, F.tularensis 15 , / .. , .. , .. , .. , .. , .. // . 2014, 35 (3). . 147-150.

13. , .. / .. , .. , .. , .. , .. , .. , .. // . 2011, 5. . 26-28.

14. , .. F.tularensis / .. , .. , .. , .. // . 2013. 4. . 14-20.

)

15. .

; . . .. , . .. . : , 2011 152 .

)

16. ; . .. , .. , .. . .: , 2010. 209 .

)

17. Firstova, V.V. Evaluation of immunospecific protection against tularemia via flow cytofluorimeter technology / V.V. Firstova, A.L. Kravtzov, T.N. Schukovskaya, T.P. Schmelkova // International School for Young Scientist and Students on Optics, Laser Physics and Biophysics. September 21-24, 2004. Saratov, Russia. . 45.

18. , .. in vitro (- -) BALB/c, Yersinia pestis EV / .. , .. , .. , .. // - - , 21-22 2009, .

2009. . 217-219.



Pages:     | 1 |   ...   | 7 | 8 || 10 |
 

:

- Stevia rebaudiana (Bertoni) Hemsley 06.01.05 ...

03.02.08 () : ...

(CERVUS ELAPHUS SIBIRICUS SEVERTZOV, 1873) (, , ) 03.02.08 ( ) : - . , .. 201 .. 4 1. .. .. 9...

IN VITRO 06.01.08 , .. 201 ...

BRUCELLA ABORTUS 19 BA, FRANCISELLA TULARENSIS 15 , YERSINIA PESTIS EV 03.02.03 :...

14.01.12 : , .. , .. , 2015 ....

Ȼ 14.01.11 : , .. 2015 1. ...

03.03.04 , , : , .....

, 03.02.02 : , .. - 1....

03.02.08 : , .. -2015 .. 1 .. 1.1. 1.2. ...

13.00.01 , ...

03.02.08 : , 2014 . 1. 1.1 ...

03.02.03 03.01.06 ( ) ...

- 03.01.06 ( ) , .. 2014 .....

- - - 06.02.03 , , . 2015 . ...

03.02.02 : , 2015 1 2 2.1 ...

03.02.07 06.01.05 ...

- 14.01.07 ...

, 14.03.09 , : , ...

ROSA L. 03.02.01 ..., 1. ROSA L. . 2. ROSA L. 2.1. Rosa L. 2.2. Rosa L. 3....







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .